Comparative tumor RNA sequencing analysis for difficult-to-treat pediatric and young adult patients with cancer

OM Vaske, I Bjork, SR Salama, H Beale… - JAMA network …, 2019 - jamanetwork.com
Importance Pediatric cancers are epigenetic diseases; therefore, considering tumor gene
expression information is necessary for a complete understanding of the tumorigenic processes…

[PDF][PDF] Genomic profiling of childhood tumor patient-derived xenograft models to enable rational clinical trial design

…, Y Sanchez, CS Greene, SJ Diskin, OM Vaske… - Cell reports, 2019 - cell.com
Accelerating cures for children with cancer remains an immediate challenge as a result of
extensive oncogenic heterogeneity between and within histologies, distinct molecular …

Phenotypic spectrum and transcriptomic profile associated with germline variants in TRAF7

…, VM Siu, E Reesor, T Yao, RA Hegele, OM Vaske… - Genetics in …, 2020 - nature.com
Purpose Somatic variants in tumor necrosis factor receptor–associated factor 7 (TRAF7) cause
meningioma, while germline variants have recently been identified in seven patients with …

TPP1 promoter mutations cooperate with TERT promoter mutations to lengthen telomeres in melanoma

…, BKN Seynnaeve, JM Kirkwood, OM Vaske… - Science, 2022 - science.org
Overcoming replicative senescence is an essential step during oncogenesis, and the
reactivation of TERT through promoter mutations is a common mechanism. TERT promoter …

[PDF][PDF] Integrated proteogenomic characterization across major histological types of pediatric brain cancer

…, N Gupta, NJ Edwards, NA Vitanza, OM Vaske… - Cell, 2020 - cell.com
We report a comprehensive proteogenomics analysis, including whole-genome sequencing,
RNA sequencing, and proteomics and phosphoproteomics profiling, of 218 tumors across 7 …

[HTML][HTML] The children's brain tumor network (CBTN)-Accelerating research in pediatric central nervous system tumors through collaboration and open science

…, HB Lindsay, AG Stucklin, N Gerber, OM Vaske… - Neoplasia, 2023 - Elsevier
Pediatric brain tumors are the leading cause of cancer-related death in children in the United
States and contribute a disproportionate number of potential years of life lost compared to …

Loss of MAT2A compromises methionine metabolism and represents a vulnerability in H3K27M mutant glioma by modulating the epigenome

…, F Lieberman, NM Amankulor, SG Wendell, OM Vaske… - Nature cancer, 2022 - nature.com
Diffuse midline gliomas (DMGs) bearing driver mutations of histone 3 lysine 27 (H3K27M)
are incurable brain tumors with unique epigenomes. Here, we generated a syngeneic …

[HTML][HTML] Barriers to accessing public cancer genomic data

…, TC Goldstein, SR Salama, D Haussler, OM Vaske… - Scientific data, 2019 - nature.com
Although increasingly recognized as critical to genomic research, genomic data sharing is
hindered by an absence of standards regarding timing, patient privacy, use agreement …

[HTML][HTML] A functional precision medicine pipeline combines comparative transcriptomics and tumor organoid modeling to identify bespoke treatment strategies for …

…, M Gokden, S Salama, CP Wardell, RL Eoff, OM Vaske… - Cells, 2021 - mdpi.com
Li Fraumeni syndrome (LFS) is a hereditary cancer predisposition syndrome caused by
germline mutations in TP53. TP53 is the most common mutated gene in human cancer, …

[HTML][HTML] Machine learning multi-omics analysis reveals cancer driver dysregulation in pan-cancer cell lines compared to primary tumors

…, D Haussler, SR Salama, OM Vaske - Communications …, 2022 - nature.com
Cancer cell lines have been widely used for decades to study biological processes driving
cancer development, and to identify biomarkers of response to therapeutic agents. Advances …